FDA Issues Warning on Use of Psychedelic Drug

In recent years, there has been a growing interest in ketamine use for treating psychiatric illnesses. Illicit ketamine use is also on the rise.

The U.S. Food and Drug Administration (FDA) in White Oak, Md., on June 5, 2023. Madalina Vasiliu/The Epoch Times

The Food and Drug Administration (FDA) on Tuesday warned patients and health care providers about the risks associated with compounded ketamine, a type of psychedelic.

In recent years, there has been a growing interest in ketamine use for treating psychiatric illnesses. Illicit ketamine use is also on the rise.